Paraneoplastic focal segmental glomerulosclerosis in a patient with lung adenocarcinoma

Internal Medicine

Volumn 52, Issue 17, 2013, Pages 1953-1956

  Tadokoro, Akira ^a   Ishii, Tomoya ^a   Takahama, Takayuki ^a   Watanabe, Naoki ^a   Takano, Koshiro ^a   Kanaji, Nobuhiro ^a   Imataki, Osamu ^a   Dobashi, Hiroaki ^a   Bandoh, Shuji ^a   Matsunaga, Takuya ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Focal segmental glomerulosclerosis; Lung cancer; Nephrotic syndrome; Paraneoplastic syndrome

Indexed keywords

CARBOPLATIN; CREATININE; DEXAMETHASONE; FLUORODEOXYGLUCOSE F 18; NAVELBINE;

AGED; ARTICLE; BACKACHE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ELECTRON MICROSCOPY; FEBRILE NEUTROPENIA; GLOMERULOSCLEROSIS; HEMATURIA; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; KIDNEY BIOPSY; LUNG ADENOCARCINOMA; LUNG HILUS; LYMPHADENOPATHY; MALE; MICROSCOPY; MULTIPLE CYCLE TREATMENT; NEPHROTIC SYNDROME; PARANEOPLASTIC FOCAL SEGMENTAL GLOMERULOSCLEROSIS; POSITRON EMISSION TOMOGRAPHY; PROTEINURIA; THORAX RADIOGRAPHY; URINALYSIS;

ADENOCARCINOMA; AGED; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; LUNG NEOPLASMS; MALE;

EID: 84883432302     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.52.0485     Document Type: Article

References (18)

1. Beckles MA, Spiro SG, Colice GL, Rudd RM. Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest 123 (1 Suppl): 97S-104S, 2003.
2. Lin FC, Chen JY, Yang AH, Chang SC. The association of nonsmall-cell lung cancer, focal segmental glomerulosclerosis, and platelet dysfunction. Am J Med Sci 324: 161-165, 2002.
3. Ronco PM. Paraneoplastic glomerulopathies: New insights into an old entity. Kidney Int 56: 355-377, 1999.
4. Bacchetta J, Juillard L, Cochat P, Droz JP. Paraneoplastic glomerular diseases and malignancies. Crit Rev Oncol Hematol 70: 39-58, 2009.
5. Daskalakis N, Winn MP. Focal and segmental glomerulosclerosis. Cell Mol Life Sci 63: 2506-2511, 2006.
6. Kodner C. Nephrotic syndrome in adults: diagnosis and management. Am Fam Physician 80: 1129-1134, 2009.
7. Ohara G, Satoh H, Kurishima K, Ohtsuka M, Hizawa N. Paraneoplastic nephrotic syndrome in patients with lung cancer. Intern Med 48: 1817-1820, 2009.
8. Loi S, Perry GJ, Standish H, Dowling J. Glomerulosclerosis: a paraneoplastic phenomenon? Nephrology (Carlton) 9: 387-391, 2004.
9. Ardizzoni A, Boni L, Tiseo M, et al. Cisplatin-versus carboplatinbased chemotherapy in first-line treatment of advanced non-smallcell lung cancer: an individual patient data meta-analysis. J Natl Cancer Inst 99: 847-857, 2007.
10. Kim YT, Rha SY, Shim CY, et al. A case of paraneoplastic nephrotic syndrome in a patient with ovarian carcinoma. Yonsei Med J 44: 539-543, 2003.
11. Teoh DC, El-Modir A. Managing a locally advanced malignant thymoma complicated by nephrotic syndrome: a case report. J Med Case Rep. Mar 19;2:89. doi: 10.1186/1752-1947-2-89, 2008
12. D'Agati VD. The spectrum of focal segmental glomerulosclerosis: new insights. Curr Opin Nephrol Hypertens 17: 271-281, 2008.
13. Schiffer M, Bitzer M, Roberts IS, et al. Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 108: 807-816, 2001.
14. Shirato I, Hosser H, Kimura K, Sakai T, Tomino Y, Kriz W. The development of focal segmental glomerulosclerosis in masugi nephritis is based on progressive podocyte damage. Virchows Arch 429: 255-273, 1996.
15. Fukuyama T, Ichiki Y, Yamada S, et al. Cytokine production of lung cancer cell lines: Correlation between their production and the inflammatory/immunological responses both in vivo and in vitro. Cancer Sci 98: 1048-1054, 2007.
16. Saji H, Nakamura H, Awut I, et al. Significance of expression of TGF-beta in pulmonary metastasis in non-small cell lung cancer tissues. Ann Thorac Cardiovasc Surg 9: 295-300, 2003.
17. Taniguchi K, Fujioka H, Torashima Y, et al. Rectal cancer with paraneoplastic nephropathy: association of vascular endothelial growth factor. Dig Surg 21: 455-457, 2004.
18. Yeong-Hau H, Lien Li-Wen. Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis. Nat Rev Nephrol 7: 85-95, 2011.